Objective To determine the economic impact of medication non-adherence across multiple
disease groups. Design Systematic review. Evidence review A comprehensive literature …

Medication adherence plays an important role in optimizing the outcomes of many treatment
and preventive regimens in chronic illness. Self-report is the most common method for …

The recommendations listed in the present guideline are, whenever possible, evidence
based. An initial extensive evidence review, which included literature derived from research …

The treatment of chronic illnesses commonly includes the long-term use of
pharmacotherapy. Although these medications are effective in combating disease, their full …

Background: Medication nonadherence is associated with worse outcomes in patients with
atherosclerotic cardiovascular disease (ASCVD), a group who requires long-term therapy for …

Aims While suboptimal adherence to statin medication has been quantified in real‐world
patient settings, a better understanding of its impact is needed, particularly with respect to …

BACKGROUND: Given the huge burden of coronary artery disease and the effectiveness of
medication therapy, understanding and quantifying known impacts of poor medication …

Improving medication adherence across the health care system is an ingredient that is vital
to improving patient outcomes and reducing downstream health care costs. The …

Non-traditional indicators of socioeconomic status (SES; eg, home ownership) may be just
as or even more predictive of health outcomes as traditional indicators of SES (eg, income) …

Introduction Previous research has shown that statin adherence for the primary prevention of
CVD is lower compared to secondary prevention populations. Therefore the aim of this …